NCT05894421 2024-03-12
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
Clinical Trials
14 trialsNCT04864418 2023-07-20
AST-021p Study in Advanced Solid Tumors
Aston Sci. Inc.
Phase 1 Unknown
NCT05192512 2022-03-03
Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05028218 2021-09-21
A Clinical Study of TQB3824 in Subjects With Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02797795 2021-03-03
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers
Neovia Oncology Ltd.
Phase 1 Unknown
NCT02779699 2019-05-21
A Study of AL2846 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02996838 2019-05-21
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03645200 2019-04-25
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Phase 1 Unknown
NCT03554889 2018-06-13
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
Hangzhou Cancer Hospital
Phase 1 Unknown
NCT03019276 2017-09-18
A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03099330 2017-09-18
A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03243643 2017-09-08
HS:Hansoh;
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT02469883 2015-06-12
A Study of Sinotecean on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT01361529 2011-05-27
Safety Study of FLP Injection to Treat Tumor Patients
Acea Bio (Hangzhou) Co., Ltd.
Phase 1 Unknown